Repetitive transcranial magnetic stimulation reduces suicidal thoughts and depression

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-06-11 03:45 GMT   |   Update On 2022-06-11 09:12 GMT

Taiwan: In a new study conducted by Guan-Wei Chen and the team it was shown that in individuals with significant mental illnesses, repeated transcranial magnetic stimulation (rTMS) proved effective and well-tolerated in lowering suicide thoughts and depression severity. The findings of this study were published in Frontiers in Psychiatry.Suicidal conduct is a major public health issue across...

Login or Register to read the full article

Taiwan: In a new study conducted by Guan-Wei Chen and the team it was shown that in individuals with significant mental illnesses, repeated transcranial magnetic stimulation (rTMS) proved effective and well-tolerated in lowering suicide thoughts and depression severity. The findings of this study were published in Frontiers in Psychiatry.

Suicidal conduct is a major public health issue across the world, accounting for 1.3 percent of all deaths. Every year, around 700,000 individuals commit suicide. Suicidal people can be treated with psychotherapy, electroconvulsive, social support intervention, treatment, and pharmacology with antidepressants, lithium, and clozapine. However, because of the complexities of suicide and the accompanying risk factors, it is difficult to recommend specific treatment protocols. Apart from the limitations in the evidence mentioned above, no meta-analysis has been conducted to quantify the effect of repetitive transcranial magnetic stimulation on suicide-related outcomes. As a result, the purpose of this study was to look at the effectiveness of repetitive transcranial magnetic stimulation in treating suicidal thoughts in individuals with mental illnesses.

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards were followed by the researchers for this study. From their creation until July 22, 2021, major electronic databases were extensively searched. The primary outcome was the mean changes in suicidal ideation scores. The mean change in depression severity was the secondary endpoint.

The key findings of this study were as follows:

1. Ten randomized controlled trials were included, including 415 participants in the active treatment group and 387 persons in the control group.

2. In people with severe mental diseases, rTMS significantly reduced suicidal ideation and the severity of depressive symptoms.

3. rTMS decreased suicidal thoughts in individuals with non-treatment-resistant depression (non-TRD) but not in those with TRD (0.208).

4. Combination treatment with rTMS exhibited a greater impact than monotherapy (0.500 vs. 0.210).

5. Suicidal thoughts decreased dramatically in participants who had more than 10 therapy sessions (-0.255).

6. Notably, the rTMS group had excellent tolerance with no severe side effects.

In conclusion, rTMS in combination with other treatments may be more successful than rTMS alone. Due to the relatively limited sample sizes included in the current investigation, larger sample sizes in future studies would aid in analyzing more confounders and conducting further subgroup analysis to determine which stimulation technique or patient group was more beneficial in suicide prevention.

Reference: 

Chen, G.-W., Hsu, T.-W., Ching, P.-Y., Pan, C.-C., Chou, P.-H., & Chu, C.-S. (2022). Efficacy and Tolerability of Repetitive Transcranial Magnetic Stimulation on Suicidal Ideation: A Systemic Review and Meta-Analysis. In Frontiers in Psychiatry (Vol. 13). Frontiers Media SA. https://doi.org/10.3389/fpsyt.2022.884390

Tags:    
Article Source : Frontiers in Psychiatry

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News